Prof. Angela Panoskaltsis-Mortari stood silently a few feet from the machine as it whirred alive for the first time. The device deposited coat atop delicate coat of pink goo through a small syringe until it had transformed a computerized image into a physical object.
Then she exhaled. Instead of wax or plastic, this 3-D printer uses "living" ink.
"It's like science fiction," said Panoskaltsis-Mortari, a pediatrics and medicine professor at the University of Minnesota.
Her lab was one of 20 worldwide selected recently to receive bioprinters from a fledgling company called BioBots, and it places her at the vanguard of research that could transform transplant medicine, burn therapy, drug testing and other fields of health care.
At labs across the country, researchers have used bioprinters like hers to produce transplantable ears, bone and muscle.
Panoskaltsis-Mortari plans to use her month-old printer to produce a biocompatible piece of esophagus; she and her colleagues hope to transplant it into a pig by the end of the year.
"The idea is that if you can generate the [right] types of cells," she said, "then all you have to do is print them in the right pattern."
Eventually, she said, medical researchers hope to "print" entire organs, such as lungs or hearts, for human transplant. On average, about 21 Americans die each day waiting for a transplant. That goal is at least a decade off, she said, but it raises tantalizing possibilities.